DXCM vs. SOLV: DexCom vs. Solventum Stock Comparison

November 11, 2026

How do DexCom (DXCM) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

DexCom (DXCM) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though DXCM is classified under Health Care Equipment while SOLV falls under Health Care Supplies.

DexCom (DXCM) carries decades of public-market history since April 14, 2005, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the DXCM side.

Company profile comparison for DexCom (DXCM) and Solventum (SOLV)
Profile Item	DXCM	SOLV
Name	DexCom Inc.	Solventum Corporation
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Supplies
Market Capitalization	29.62 billion USD	15.36 billion USD
Currency	USD	USD
Exchange	Nasdaq	NYSE
Listing Date	April 14, 2005	March 26, 2024
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

DXCM

SOLV

GSPC

DexCom (DXCM) vs. Solventum (SOLV), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for DexCom (DXCM) and Solventum (SOLV). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for DexCom (DXCM) and Solventum (SOLV). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
Total Return (1Y)	46.33%	25.89%
Total Return (3Y, Annualized)	-4.50%	--
Total Return (5Y, Annualized)	-12.76%	--

Risk Profile

Drawdown History

DXCM

SOLV

GSPC

DexCom (DXCM) vs. Solventum (SOLV), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for DexCom (DXCM) and Solventum (SOLV). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

DexCom (DXCM) has an aggressive beta of 1.43, indicating higher sensitivity to broad-market moves, while Solventum (SOLV) is defensive at 0.62 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
Volatility (1Y, Annualized)	38.37%	30.06%
Beta (5Y)	1.43	0.62
Max Drawdown (5Y)	-66.32%	-39.98%
Avg. Volume (3M)	4.34M	1.05M

Risk-Adjusted Performance

Risk-Return Positioning

DXCM and SOLV are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
Sharpe Ratio (1Y)	1.10	0.72
Sortino Ratio (1Y)	1.79	1.08

Profitability

ROE (TTM)

DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Solventum (SOLV) at 3.19% is closer to the peer norm — stronger capital efficiency for DXCM.

DXCM

Health Care Equipment & Services industry group

37.67%

Max: 47.61%
DXCM: 37.67%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

SOLV

Health Care Equipment & Services industry group

3.19%

Max: 47.61%
Q3: 14.36%
Median: 5.45%
SOLV: 3.19%
Q1: -10.67%
Min: -47.01%

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

DexCom (DXCM) at 19.42% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.

DXCM

Health Care Equipment & Services industry group

19.42%

Max: 29.35%
DXCM: 19.42%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

SOLV

Health Care Equipment & Services industry group

1.91%

Max: 29.35%
Q3: 9.33%
Median: 2.18%
SOLV: 1.91%
Q1: -6.29%
Min: -28.46%

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

DexCom (DXCM) at 24.34% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.

DXCM

Health Care Equipment & Services industry group

24.34%

Max: 35.43%
DXCM: 24.34%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

SOLV

Health Care Equipment & Services industry group

6.82%

Max: 35.43%
Q3: 14.14%
SOLV: 6.82%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
ROE (TTM)	37.67%	3.19%
ROA (TTM)	11.14%	2.29%
Net Margin (TTM)	19.42%	1.91%
Operating Margin (TTM)	24.34%	6.82%
Gross Margin (TTM)	63.42%	55.13%

Growth

Revenue Growth

DexCom (DXCM) at 15.60% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both companies show strong earnings momentum, but Solventum (SOLV) at 221.74% is the standout with EPS growth above its industry range; DexCom (DXCM) at 47.18% also sits in the top quartile.

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
Revenue Growth (YoY)	15.60%	0.86%
Revenue Growth (3Y CAGR)	17.01%	0.79%
EPS Growth (YoY)	47.18%	221.74%
EPS Growth (3Y CAGR)	36.60%	4.51%

Financial Strength

Current Ratio (MRQ)

DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.

DXCM

Health Care Equipment & Services industry group

1.74

Max: 7.59
Q3: 4.00
Median: 1.98
DXCM: 1.74
Q1: 1.37
Min: 0.30

SOLV

Health Care Equipment & Services industry group

1.03

Max: 7.59
Q3: 4.00
Median: 1.98
Q1: 1.37
SOLV: 1.03
Min: 0.30

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

DexCom (DXCM) at 0.55 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.

DXCM

Health Care Equipment & Services industry group

0.55

Max: 1.88
Q3: 0.91
Median: 0.58
DXCM: 0.55
Q1: 0.16
Min: 0.00

SOLV

Health Care Equipment & Services industry group

1.10

Max: 1.88
SOLV: 1.10
Q3: 0.91
Median: 0.58
Q1: 0.16
Min: 0.00

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
Current Ratio (MRQ)	1.74	1.03
Debt / Equity (MRQ)	0.55	1.10
Net Debt / EBITDA	-0.28	4.66

Dividends

Dividend Yield (TTM)

Neither DexCom (DXCM) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

DXCM

Health Care Equipment & Services industry group

0.00%

DXCM: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SOLV

Health Care Equipment & Services industry group

0.00%

SOLV: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Neither DexCom (DXCM) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

DXCM

Health Care Equipment & Services industry group

0.00%

DXCM: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SOLV

Health Care Equipment & Services industry group

0.00%

SOLV: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
Dividend Yield (TTM)	0.00%	0.00%
Dividend Payout Ratio (TTM)	0.00%	0.00%

Valuation

P/E Ratio (TTM)

DexCom (DXCM) at 31.26 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.

DXCM

Health Care Equipment & Services industry group

31.26

Max: 80.41
Q3: 47.62
DXCM: 31.26
Median: 29.93
Q1: 21.19
Min: 4.21

SOLV

Health Care Equipment & Services industry group

101.55

SOLV: 101.55
Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
Min: 4.21

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

Solventum (SOLV) at 1.88 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.

DXCM

Health Care Equipment & Services industry group

5.80

Max: 8.80
DXCM: 5.80
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

SOLV

Health Care Equipment & Services industry group

1.88

Max: 8.80
Q3: 4.32
Median: 2.13
SOLV: 1.88
Q1: 1.10
Min: 0.03

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Solventum (SOLV) at 3.20 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.

DXCM

Health Care Equipment & Services industry group

11.68

DXCM: 11.68
Max: 11.68
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

SOLV

Health Care Equipment & Services industry group

3.20

Max: 11.68
Q3: 6.12
SOLV: 3.20
Median: 3.00
Q1: 1.73
Min: -1.31

DexCom (DXCM) vs. Solventum (SOLV): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for DexCom (DXCM) and Solventum (SOLV)
Metric	DXCM	SOLV
P/E Ratio (TTM)	31.26	101.55
P/S Ratio (TTM)	5.80	1.88
P/B Ratio (MRQ)	11.68	3.20
Free Cash Flow Yield (TTM)	2.74%	1.31%